骨髓瘤,麻疹病毒 z-bo 2020-10-19 333

　　Researchers at the York Clinic in May in the United States recently reported that they "cured" an American woman with multiple myeloma who had been treated with an ultra-high dose of the measles virus. However, the researchers also emphasized that this therapy is still in the early stages of human trials. According to the latest issue of the Mayo Clinic Journal, the 49-year-old woman’s cancer had spread to her entire body, and the 3 cm diameter tumor had grown to her forehead before receiving treatment. The sore virus therapy developed by the researchers selectively killed myeloma plasma cells. After maintaining a single injection for more than 6 months, the woman achieved "complete remission".

　　Another 65-year-old woman with multiple myeloma did not get the expected results after receiving the same treatment. However, the researchers say that imaging technology clearly shows that the injected scallop virus still targets female myeloma plasma cells. It should be emphasized that the scalp vaccine usually does not contain 10,000 units of scallop virus, and the two patients in this study have never been exposed to the rash. They started to use 1 million units of virus for treatment, and eventually only 100 billion units of virus can see this effect, which is enough to provide 10 million people with a sclerotherapy vaccine. Before accepting this experimental treatment, the researchers stated that the two patients had no other treatment options for tumor expansion. Regarding the importance of this result, researchers found that "viral therapy", which uses a virus to infect and destroy cancer cells without damaging normal tissues, can effectively treat deadly multiple myeloma.